GeneDx Holdings Corp. (WGS)
GeneDx Holdings Market Cap : 2.372B for Feb. 20, 2026
Market Cap Chart
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| Illumina, Inc. | 17.99B |
| Guardant Health, Inc. | 13.39B |
| Quest Diagnostics, Inc. | 22.31B |
| Labcorp Holdings, Inc. | 23.43B |
| Natera, Inc. | 29.58B |
Market Cap Related Metrics
| PE Ratio | 1360.86 |
| PS Ratio | 5.852 |
| Price to Book Value | 8.116 |
| Price to Free Cash Flow | 152.17 |
| Price | 82.06 |
| Earnings Yield | 0.07% |
| Operating PE Ratio | 213.65 |
| Normalized PE Ratio | 421.90 |